The founder of Vertex Pharmaceuticals Inc. has rejoined the biotech world, ... PittsburghPortlandProvidenceRaleigh/DurhamSacramentoSan AntonioSan ...
News
- Vertex founder Josh Boger is back in biotech. Here's why he 'un-retired.' - Boston Business Journal
- Capivasertib in combination with FASLODEX® (fulvestrant) granted Priority Review in ... - BioSpace
The NDA is based on data from the CAPItello-291 Phase III trial presented at the 2022 San Antonio Breast Cancer Symposium and recently published ...
- Lantern Pharma Receives FDA Clearance of IND Application for Drug Candidate LP ... - BioSpace
... the Society for Neuro-Oncology annual meeting, the San Antonio Breast Cancer Symposium, and the Frontiers in Drug Discovery Journal.
- Magic cocktail generates lung's most critical immune cell in the lab - Newswise
Newswise — SAN ANTONIO (June 12, 2023) — Researchers at Texas Biomedical Research Institute have succeeded in generating the lung's most important ...
- Rockville biotech OpGen faces delisting threat from Nasdaq - Washington Business Journal
... YorkOrlandoPhiladelphiaPhoenixPittsburghPortlandProvidenceRaleigh/DurhamSacramentoSan AntonioSan FranciscoSeattleSilicon ValleySt. LouisTampa ...